Kate Rochlin

Kate Rochlin

Company: IN8bio

Job title: Chief Operating Officer


Panel Discussion: What Needs to be Done to Fully Capitalize on the Promise of Genetic Engineering to Produce Scalable & Clinically Efficacious Gamma Delta T Cells? 4:15 pm

Debating the need for genetic engineering to enable strong clinical results Comparing and contrasting the need for CARs or other types of gene engineering to enhance efficacy Leveraging different engineering technologies to equip gamma delta Ts with the genetic capabilities to maximize persistenceRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.